CAR-NK cell therapy trial for advanced liver cancer

This document registers a new clinical trial on ClinicalTrials.gov under protocol NCT07500220, evaluating chimeric antigen receptor natural killer (CAR-NK) cell therapy for treatment of advanced liver cancer. The trial is categorized as an interventional study focusing on this novel immunotherapy modality.

Healthcare institutions and clinical investigators interested in cellular therapy research should review this protocol registration for potential enrollment opportunities or collaborative research considerations. Sponsors conducting similar CAR-NK or liver cancer trials should ensure their own studies are properly registered on ClinicalTrials.gov in accordance with FDA requirements for clinical trial registration.